Scope: Valuation by scheme
Oxford Biomedica

Source: 2024 annual report, p. 124 FRC review

Financial Reporting Council
Thematic review · October 2025
Annual report extracts alongside the Financial Reporting Council’s assessment.
Independent report of FRC findings
Explore UK annual report examples of IFRS 2 share-based payment disclosures, including practical approaches to valuation, settlement and group reporting.
Scope: Valuation by scheme

Source: 2024 annual report, p. 124 FRC review
Scope: Cash-settled awards

Source: 2024 annual report, p. 144 FRC review
Scope: Parent-company accounts

Source: 2024 annual report, p. 3.54 FRC review
Scope: Employee benefit trust

Source: 2024 annual report, p. 155 FRC review
Scope: Deferred tax in equity

Source: 2025 annual report, p. 130 FRC review
Scope: Employer National Insurance

Source: 2025 annual report, p. 184 FRC review
Scope: Grouping similar schemes

Source: 2024 annual report, p. 508 FRC review
Scope: Grouping with a separate exception

Source: 2024 annual report, p. 69 FRC review
Scope: Remuneration report cross-reference

Source: 2024 annual report, p. 107 FRC review
Scope: IFRS 2 or IFRS 9

Source: 2024 annual report, pp. 143–144 FRC review
Scope: Excluding the charge from adjusted EBITDA

Source: 2024 annual report, p. 154 FRC review
Scope: Putting the charge back into the measure

Source: 2025 annual report, p. 30 FRC review
Scope: Share-based payment reserve

Source: 2024 annual report, p. 228 FRC review